Fragmentation and site-specific quantification of core fucosylated glycoprotein by multiple reaction monitoring-mass spectrometry.

Glycosylation modifications of proteins have been attracting increasing attention due to their roles in the physiological and pathological processes of the cell. Core fucosylation (CF), one special type of glycan structure in glycoproteins, has been linked with tumorigenesis. The study of protein glycosylation has been hindered by the technical challenges caused by the microheterogeneity of glycan modifications. In commonly used methods, sugar chains on the peptide were released using endoglycosidase, and the glycan and peptides were analyzed separately with mass spectrometry. Although mass spectrometric analysis can be performed easily in this way, an increase in false positives when assigning glycosites was inevitable. Our earlier research demonstrated a strategy combining Endo F3-catalyzed partial deglycosylation with MS(3) (MS/MS/MS) scanning triggered by the neutral loss of a fucose to precisely identify CF proteins on a large scale. In this research, fragmentations of partially deglycosylated glycopeptides were studied using a triple quadrupole mass spectrometer, and a quantification method that coupled our published identification strategy with multiple reaction monitoring-mass spectrometry (MRM-MS) analysis was developed to obtain site-specific quantification information of core fucosylated peptides. To illustrate the feasibility of the quantification method, the CF peptides of target proteins in clinical serum were quantified and compared as a preliminary demonstration.

[1]  Yuan Tian,et al.  Glycoproteomics and clinical applications , 2010, Proteomics. Clinical applications.

[2]  Keiichiro Suzuki,et al.  High expression of α‐1‐6 fucosyltransferase during rat hepatocarcinogenesis , 1998 .

[3]  Yan Li,et al.  Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues. , 2011, Analytical chemistry.

[4]  Simon J North,et al.  Mass spectrometry in the analysis of N-linked and O-linked glycans. , 2009, Current opinion in structural biology.

[5]  Yehia Mechref,et al.  Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. , 2005, Analytical chemistry.

[6]  E. Kimes,et al.  Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results , 2023, Journal of Korean medical science.

[7]  Osamu Ishikawa,et al.  Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation , 2006, International journal of cancer.

[8]  Mary Ann Comunale,et al.  Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. , 2006, Journal of proteome research.

[9]  Mary Ann Comunale,et al.  Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2009, Cancer Epidemiology Biomarkers & Prevention.

[10]  Ji Yeon Lee,et al.  Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. , 2009, Journal of proteome research.

[11]  R. Contreras,et al.  Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics , 2004, Nature Network Boston.

[12]  Ying Jiang,et al.  Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer. , 2010, Journal of proteome research.

[13]  A. Pandey,et al.  18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma , 2008, Clinical Proteomics.

[14]  Baruch S Blumberg,et al.  Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Hao Chi,et al.  A Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins*S , 2009, Molecular & Cellular Proteomics.

[16]  X. Yao,et al.  Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. , 2001, Analytical chemistry.

[17]  Chi-Huey Wong,et al.  Protein glycosylation: new challenges and opportunities. , 2005, The Journal of organic chemistry.

[18]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[19]  Hyun Joo An,et al.  Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. , 2009, Current opinion in chemical biology.

[20]  Pauline M Rudd,et al.  Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. , 2007, Glycobiology.

[21]  Development of Serum Glycoproteomic Profiling Technique; Simultaneous Identification of Glycosylation Sites and Site-Specific Quantification of Glycan Structure Changes* , 2010, Molecular & Cellular Proteomics.

[22]  Hoguen Kim,et al.  Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. , 2010, Journal of proteome research.

[23]  P. Højrup,et al.  Utilizing ion-pairing hydrophilic interaction chromatography solid phase extraction for efficient glycopeptide enrichment in glycoproteomics. , 2010, Analytical chemistry.

[24]  Olga Vitek,et al.  Correlation between y-type ions observed in ion trap and triple quadrupole mass spectrometers. , 2009, Journal of proteome research.

[25]  Ronald J Moore,et al.  Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. , 2005, Journal of proteome research.

[26]  H. Tsubouchi,et al.  Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers , 2010, Proteome Science.

[27]  Naoyuki Taniguchi,et al.  Gene expression of α1‐6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α‐fetoprotein , 1998 .

[28]  Daniel Kolarich,et al.  Quantitative N-linked Glycoproteomics of Myocardial Ischemia and Reperfusion Injury Reveals Early Remodeling in the Extracellular Environment* , 2011, Molecular & Cellular Proteomics.

[29]  R. Dwek,et al.  Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. , 2007, Glycobiology.

[30]  J. Ko,et al.  Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry. , 2010, Analytical chemistry.

[31]  S. Nishimura,et al.  Sialic Acid-focused Quantitative Mouse Serum Glycoproteomics by Multiple Reaction Monitoring Assay* , 2010, Molecular & Cellular Proteomics.

[32]  Lingjun Li,et al.  Comparative glycoproteomics: approaches and applications. , 2009, Briefings in functional genomics & proteomics.

[33]  M. Mizuno,et al.  Derivatization with 1-pyrenyldiazomethane enhances ionization of glycopeptides but not peptides in matrix-assisted laser desorption/ionization mass spectrometry. , 2010, Analytical chemistry.